Reference health
Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial
71171-4/badge.svg){kind=icon}
17/17 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 17 checked references that resolve
resolves10.1093/jnci/dji372
Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
resolves10.1093/jnci/90.18.1371
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
resolves10.1093/jnci/djk050
Twenty-Year Follow-up of the Royal Marsden Randomized, Double-Blinded Tamoxifen Breast Cancer Prevention Trial
resolves10.1016/S0140-6736(02)09962-2
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial
resolves10.1093/jnci/djk049
Long-Term Results of Tamoxifen Prophylaxis for Breast Cancer--96-Month Follow-up of the Randomized IBIS-I Trial
resolves10.1093/jnci/95.2.160
Italian Randomized Trial Among Women With Hysterectomy: Tamoxifen and Hormone-Dependent Breast Cancer in High-Risk Women
resolves10.1016/S0140-6736(98)85012-5
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
resolves10.1016/S0140-6736(13)60140-3
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data
resolves10.1016/S0140-6736(98)04394-3
Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women
resolves10.1093/jnci/djk154
Tamoxifen for the Prevention of Breast Cancer: Late Results of the Italian Randomized Tamoxifen Prevention Trial Among Women With Hysterectomy
resolves10.1016/S0140-6736(13)62292-8
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial
resolves10.1093/biomet/67.1.145
Chi-squared goodness-of-fit tests for the proportional hazards regression model
resolves10.1016/S0140-6736(11)60993-8
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
resolves10.1016/S0140-6736(03)12342-2
Overview of the main outcomes in breast-cancer prevention trials
The 2 references without a DOI — listed, not checked
no DOI — not checkedGlobal cancer statistics
no DOI — not checked10.1016/S1470-2045(14)71171-4_bib14
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/s1470-2045(14)71171-4"><img src="https://citestamp.com/citestamped/10.1016/s1470-2045(14)71171-4/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[71171-4/badge.svg)](https://citestamp.com/citestamped/10.1016/s1470-2045(14)71171-4)